Evidence map›Paper›PMID 42199729›Full record

ArticleOphthalmology science2026

Marker-Free, Automated Eyelid Assessment in Thyroid Eye Disease Using Artificial Intelligence: A Multicenter Validation Study.

Jae Hoon Moon, Jongchan Kim, Joonhyeon Park, Min Joo Kim, Tae Jung Oh, Joon Ho Moon, Sung Hye Kong, Kyubo Shin, Jaemin Park, Jin Sook Yoon and 9 more

Abstract read
In one paragraph

Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jae Hoon MoonTHYROSCOPE INC., Ulsan, Republic of Korea.
Jongchan KimTHYROSCOPE INC., Ulsan, Republic of Korea.
Joonhyeon ParkTHYROSCOPE INC., Ulsan, Republic of Korea.
Min Joo KimDepartment of Internal Medicine, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam, Republic of Korea.
Tae Jung OhDepartment of Internal Medicine, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam, Republic of Korea.
Joon Ho MoonDepartment of Internal Medicine, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam, Republic of Korea.
Sung Hye KongDepartment of Internal Medicine, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam, Republic of Korea.
Kyubo ShinTHYROSCOPE INC., Ulsan, Republic of Korea.
Jaemin ParkTHYROSCOPE INC., Ulsan, Republic of Korea.
Jin Sook YoonDepartment of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea.
JaeSang KoDepartment of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea.
Won Sang YooDepartment of Internal Medicine, Dankook University College of Medicine, Cheonan, Republic of Korea.
Raquel Monge CarmonaDepartment of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain.
Marina Soto SierraDepartment of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain.
Luz María Valverde CanoDepartment of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain.
Tomás Martín HernándezDepartment of Endocrinology and Nutrition, Virgen Macarena University Hospital, Seville, Spain.
Mariola Méndez MurosRICORS-REI, Institute of Health Carlos III, Madrid, Spain.
Namju KimDepartment of Ophthalmology, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam, Republic of Korea.
Antonio Manuel Garrido HermosillaDepartment of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To validate "Glandy LID," a novel marker-free, deep learning-based software designed for the automated assessment of eyelid morphology using intrinsic corneal diameter for calibration. Design: Multicenter retrospective study. Participants: The internal validation cohort consisted of 119 patients with thyroid eye disease (TED) from Seoul National University Bundang Hospital (South Korea). The external validation cohort included 140 patients from Hospital Universitario Virgen Macarena (Spain). Methods: An artificial intelligence (AI) algorithm segmented eyelid and corneal regions from facial photographs. Eyelid metrics were calculated using population-specific corneal diameters as a reference scale for pixel-to-millimeter conversion. The internal cohort utilized digital single-lens reflex images compared against ground truth derived from physical markers. The external cohort utilized smartphone-captured images compared against clinical medical records to assess clinical generalizability. Main Outcome Measures: Geometric precision was assessed using Intersection over Union. Accuracy of quantitative measurements (margin reflex distance 1 [MRD1] and 2 [MRD2]) was evaluated using Pearson correlation coefficient (PCC), mean absolute error, and mean absolute percentage error (MAPE). Results: In the internal validation, the AI system demonstrated high geometric precision (Intersection over Union 0.94). Quantitative measurements showed excellent agreement with the ground truth, achieving a PCC of 0.98 for MRD1 and 0.94 for MRD2, with low MAPEs of 5.69% and 4.57%, respectively. In the external validation using smartphone images without markers, the system maintained high reliability. For MRD1, it achieved a PCC of 0.94 and a MAPE of 9.06%. Although MRD2 showed a slightly higher MAPE (15.07%), likely due to manual measurement variability in clinical records, the correlation remained strong (PCC 0.93). Conclusions: This AI system provides an accurate and robust automated solution for eyelid measurement without the need for physical reference markers. By overcoming the limitations of manual assessment and marker-based systems, this tool offers a practical and accessible method for objectively monitoring TED in both routine clinical practice and remote health care settings. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Artificial intelligenceDeep learningEyelid retractionTelemedicineThyroid eye disease

Identifiers

PMID42199729
PMCPMC13199772

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.